Both MSC-CD3 and MSC-CD40L controlled tumor growth better than MSC, but combination treatment with MSC-CD3-CD40L had the greatest antitumor efficacy and significantly increased survival (Figure 1, F and G). Here, CD40LG is linked to neoplasm.